by | PRNewswire Asia
Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting SEOUL, South Korea, April 22, 2026 /PRNewswire/ — ViGenCell Inc. (KOSDAQ: 308080), a clinical-stage biotechnology company based in South Korea focused on advanced...
by | PRNewswire Asia
MACAU, April 21, 2026 /PRNewswire/ — The St. Regis Bar Macao is pleased to present an exclusive collaboration with Venchi, the esteemed Italian chocolatier with over 145 years of heritage. From April 16, 2026 onwards, this partnership will unveil a bespoke...
by | PRNewswire Asia
KEEP ME UP. HOLD TIGHT. KEEP GOING.Limited-Edition Collectible Keychains Drop NowYour Bag, Your Keys, Your Everyday Download high-resolution images: https://bit.ly/4tw4GyF HONG KONG, April 21, 2026 /PRNewswire/ — At the intersection of two 27s—Keung To...
by | PRNewswire Asia
CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ — Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry’s first...
by | PRNewswire Asia
AXENS, IFPEN and JEPLAN have completed a recycling loop for polyester textiles. PARIS, April 21, 2026 /PRNewswire/ — Several tens of tons of post-consumer, polyester-rich, European textile wastes, sorted and prepared in France, have been processed in the Axens,...
by | PRNewswire Asia
Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA® (infliximab-dyyb) Findings emphasize clinical decision-making in long-term...
